Ofatumumab, CAS [[679818-59-8]]

Produktübersicht

• Artikelname: Ofatumumab, CAS [[679818-59-8]]
• Artikelnummer: MCE-HY-P9961
• Hersteller Artikelnummer: HY-P9961
• Alternativnummer: MCE-HY-P9961-10MG,MCE-HY-P9961-5MG,MCE-HY-P9961-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: GSK1841157, OMB-157

Produktbeschreibung

Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) in CD20-expressing B lymphocytes. Ofatumumab has strong lytic activity against CD20-positive B lymphocytes and eliminates CD20-positive tumor cells through ADCC and CDC. Ofatumumab is particularly effective against drug-resistant cells with low CD20 expression and can be applied to the research of chronic lymphocytic leukemia (CLL)[1][2][3].

Produkteigenschaften

• Molekulargewicht: (145.94 kDa)
• Reinheit: 99.00
• CAS Nummer: [679818-59-8]
• Target-Kategorie: CD20

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies